Vertaling van "available that have been validated " (Nederlands → Frans) :

Though we have just seen that there is a large consensus on the definition of depression and that there are diagnostic assessment tools available that have been validated internationally, things are entirely different with the term “depressiveness”.
Si comme nous venons de le voir, il existe un large consensus sur la définition de la dépression et que des outils d’évaluation diagnostique existent et sont validés internationalement, il en va tout autrement du terme « dépressivité ».

They also aim to find out whether the patients are satisfied with the help provided, whether the latter intend to consult their GP in case of a crisis, what their present psychosocial functioning is and whether there were any recurrences of suicidal behaviour. The psychosocial functioning is measured by means of the following instruments (which have been validated internationally): the General Health Questionnaire (GHQ12), the Beck Hopelessness Scale (BHS), the Positive and Negative Affectivity Scale (PANAS).
Le fonctionnement psychosocial est mesuré à l’aide des instruments suivants (validés internationalement): General Health Questionnaire (GHQ12), l’échelle de Beck, qui évalue l’anxiété et la dépression, Positive and Negative Affectivity Scale (PANAS).

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

The recommendations made in this report are based on the available epidemiological data, the main observations that have been made with regard to the problem and an inventory of the actions already put in place in Belgium.
Les recommandations émises découlent des données épidémiologiques disponibles, des principaux constats établis par rapport au problème et d’un inventaire d’actions déjà mises en place en Belgique.

There are few studies available in Belgium that have been carried out a national level and deal with the general population.
Peu d’études ont été réalisées à l’échelle nationale et sur la population générale en Belgique.

With no systematic records available of the attempted suicides that have been seen by a doctor, the data concerning attempted suicides are also often collected by means of general population surveys.
En l’absence d’enregistrement systématique des tentatives de suicide aboutissant auprès d’un médecin, les données sur les tentatives de suicide sont souvent recueillies également par le biais d’enquête en population générale.

As a result of this lack of availability, the care provided is often restricted to a vague nosographic diagnosis and a decision to admit the patients in question to the psychiatric department (the cost of which might have been saved) or to send them to a consultation. Attention is only paid to the “identified patient” rather than to devising a real therapeutic follow-up that involves the complete system.
Par ce manque de disponibilité, l’intervention se limite souvent à un vague diagnostic nosographique et à une décision d’hospitalisation en service de psychiatrie (dont on aurait pu faire l’économie) ou d’envoi en consultation, portant leur attention sur le seul « patient désigné » plutôt que d’amorcer un véritable suivi thérapeutique avec l’ensemble du système. ♦ une méconnaissance des ressources du réseau psychosocial: « Travailler avec

Average Wholesale Price litigation Claims have been brought against various pharmaceutical companies, including NPC and certain Sandoz entities, alleging that they fraudulently overstated the Average Wholesale Price and “best price”, which are, or have been, used by the US federal and state governments in the calculation of, respectively, Medicare reimbursements and Medicaid rebates. In some cases, motions to dismiss or (cross-) motions for summary judgment in other cases have been made and are currently pending.
Litige concernant le prix de gros moyen Des plaintes ont été déposées contre différentes sociétés pharmaceutiques, dont NPC et certaines entités de Sandoz, au motif que celles-ci auraient frauduleusement exagéré le prix de gros moyen (average wholesale price [AWP]) et le «meilleur prix» qui sont ou ont été utilisés par le gouvernement fédéral américain et des gouvernements d’Etat pour calculer les remboursements des médicaments dans le cadre du programme Medicare et les rabais dans celui de Medicaid.

Average Wholesale Price litigation Claims have been brought against various pharmaceutical companies, including NPC and certain Sandoz entities, alleging that they fraudulently overstated the Average Wholesale Price and “best price”, which are, or have been, used by the US federal and state governments in the calculation of, respectively, Medicare reimbursements and Medicaid rebates. In some cases, motions to dismiss or (cross-) motions for summary judgment have been made and are currently pending.
Litige concernant le prix de gros moyen Des plaintes ont été déposées contre différentes sociétés pharmaceutiques, dont NPC et certaines entités de Sandoz, au motif que celles-ci auraient frauduleusement exagéré le prix de gros moyen (average wholesale price [AWP]) et le «meilleur prix» qui sont ou ont été utilisés par le gouvernement fédéral américain et des gouvernements d’Etat pour calculer les remboursements des médicaments dans le cadre du programme Medicare et les rabais dans celui de Medicaid.

Analysis by region Attempted suicides, both those that have been committed sometime during one’s existence and those that have been committed recently, are less frequent in the Flemish region (2% and 0,3% respectively) than in the other two regions (6% and 0,6% in each of the other regions, respectively).
Analyse par régions: Les tentatives de suicide , que ce soit au cours de la vie ou commises récemment au moment de l’enquête sont moins fréquentes en région flamande (2 % et 0,3 % respectivement) que dans les deux autres régions (6 % et 0,6 % respectivement dans chacune des régions).